<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00889005</url>
  </required_header>
  <id_info>
    <org_study_id>Shalev_Phone_2009</org_study_id>
    <nct_id>NCT00889005</nct_id>
  </id_info>
  <brief_title>Prevention of Post-traumatic Stress Disorder by Telephone Based Cognitive Behavioral Therapy</brief_title>
  <official_title>Prevention of Post-traumatic Stress Disorder by Telephone Based Cognitive Behavioral Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled study comparing telephone-based cognitive behavioral therapy
      (CBT) for recent survivors of traumatic events with Acute Stress Disorder (ASD) or acute PTSD
      with a waitlist control group. Survivors with PTSD from both groups will receive face-to-face
      CBT one month from the traumatic event. The study's main hypothesis is that early
      telephone-based CBT will reduce the prevalence of PTSD three and eight months after the
      traumatic event.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Post-traumatic Stress Disorder (PTSD) is a prevalent and pervasive mental disorder. Studies
      have shown that there is a significant reluctance to use mental health services by
      trauma-exposed individuals at high risk for developing PTSD. Providing clinical services in
      combat or disaster zone might be difficult. Trauma-focused cognitive behavioral therapy (CBT)
      effectively reduces the prevalence of PTSD among recent survivors. Telephone based CBT was
      found to be effective in mood and anxiety disorders, but has not been tried in PTSD.
      Establishing the effectiveness of telephone based CBT has significant service delivery and
      public health implications. Preventing PTSD significantly reduces individuals' suffering and
      disability We will screen, by telephone, up to 1200 survivors of traumatic events, from a
      general hospital emergency department trauma registry list, randomize the first 240 with ASD
      or Acute PTSD to either early, telephone based cognitive behavioral therapy (ET_CBT) (n=120)
      or a no-treatment control condition (n=120). We will provide five sessions of ET-CBT to the
      former and compare the two groups three and eight months later.

      Survivors from both groups who will continue to have PTSD at three months (after either
      treatment or waiting list), will receive 12 sessions of face-to-face, trauma focused CBT. A
      first phase of the study will consist of establishing the acceptance of ET-CBT and its main
      components (e.g., exposure to traumatic reminders) by survivors, and optimizing the protocol.
      It will involve 20 survivors and no randomization. Subsequent to that phase we will start
      recruiting for the main study. The study's main hypothesis is that early CBT will reduce the
      prevalence of PTSD three and eight months after the traumatic event.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Severity of PTSD Symptoms</measure>
    <time_frame>Up to ten months</time_frame>
    <description>Clinician Administered PTSD Scale for DSM IV (CAPS IV) Score range 0-136 points Score above 40 indicate probable PTSD PTSD diagnosis inferred using DSM IV diagnostic criteria</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">139</enrollment>
  <condition>Stress Disorder - Post-traumatic (Acute)</condition>
  <arm_group>
    <arm_group_label>Cognitive Behavioral Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Five sessions of trauma-focused, telephone based cognitive behavioral therapy, followed by assessment and referral to clinical treatment if needed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Waitlist control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Five weeks without active intervention, followed by assessment and referral to clinical treatment if needed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Telephone Based Cognitive Behavioral Therapy</intervention_name>
    <description>Five biweekly sessions of telephone based, trauma focused cognitive behavioral therapy with homework assignment</description>
    <arm_group_label>Cognitive Behavioral Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults

          -  Exposure to psychologically traumatic events

          -  Diagnosis of Acute Stress Disorder or Post-traumatic Stress Disorder

          -  Up to four weeks after trauma exposure

        Exclusion Criteria:

          -  Chronic PTSD

          -  Past and present psychosis, bipolar disorder, opiate or stimulants use

          -  Medical or surgical condition that interfere with subjects ability to participate in
             the study or sign an informed consent

          -  Lack of fluency in the study's main language (Hebrew)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arieh Y Shalev, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah University Hospital, Jerusalem</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hadassah University Hospital</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <study_first_submitted>April 26, 2009</study_first_submitted>
  <study_first_submitted_qc>April 26, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 28, 2009</study_first_posted>
  <results_first_submitted>February 17, 2016</results_first_submitted>
  <results_first_submitted_qc>February 20, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">November 1, 2018</results_first_posted>
  <last_update_submitted>February 20, 2018</last_update_submitted>
  <last_update_submitted_qc>February 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hadassah Medical Organization</investigator_affiliation>
    <investigator_full_name>Aria Shalev</investigator_full_name>
    <investigator_title>Professor of Psychiatry</investigator_title>
  </responsible_party>
  <keyword>Post-traumatic Stress Disorder</keyword>
  <keyword>Acute Stress Disorder</keyword>
  <keyword>Cognitive behavioral therapy</keyword>
  <keyword>Secondary Prevention</keyword>
  <keyword>Anxiety disorders</keyword>
  <keyword>Service Delivery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Cognitive Behavioral Therapy</title>
          <description>Five sessions of trauma-focused, telephone based cognitive behavioral therapy, followed by assessment and referral to clinical treatment if needed.
Telephone Based Cognitive Behavioral Therapy: Five biweekly sessions of telephone based, trauma focused cognitive behavioral therapy with homework assignment</description>
        </group>
        <group group_id="P2">
          <title>Waitlist Control Group</title>
          <description>Five weeks without active intervention, followed by assessment and referral to clinical treatment if needed.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="65"/>
                <participants group_id="P2" count="74"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="57"/>
                <participants group_id="P2" count="72"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Recent trauma survivors recruited following admission to a general hospital emergency room following traumatic events. Consecutive survivors screened and enrolled if eligible</population>
      <group_list>
        <group group_id="B1">
          <title>Cognitive Behavioral Therapy</title>
          <description>Five sessions of trauma-focused, telephone based cognitive behavioral therapy, followed by assessment and referral to clinical treatment if needed.
Telephone Based Cognitive Behavioral Therapy: Five biweekly sessions of telephone based, trauma focused cognitive behavioral therapy with homework assignment</description>
        </group>
        <group group_id="B2">
          <title>Waitlist Control Group</title>
          <description>Five weeks without active intervention, followed by assessment and referral to clinical treatment if needed.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="65"/>
            <count group_id="B2" value="74"/>
            <count group_id="B3" value="139"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37.83" spread="12.2"/>
                    <measurement group_id="B2" value="37.95" spread="12.71"/>
                    <measurement group_id="B3" value="37.89" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="65"/>
                    <measurement group_id="B2" value="74"/>
                    <measurement group_id="B3" value="139"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Israel</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65"/>
                    <measurement group_id="B2" value="74"/>
                    <measurement group_id="B3" value="139"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Severity of PTSD Symptoms</title>
        <description>Clinician Administered PTSD Scale for DSM IV (CAPS IV) Score range 0-136 points Score above 40 indicate probable PTSD PTSD diagnosis inferred using DSM IV diagnostic criteria</description>
        <time_frame>Up to ten months</time_frame>
        <population>Survivors of traumatic event with Acute PTSD symptoms one month after trauma exposure</population>
        <group_list>
          <group group_id="O1">
            <title>Cognitive Behavioral Therapy</title>
            <description>Five sessions of trauma-focused, telephone based cognitive behavioral therapy, followed by assessment and referral to clinical treatment if needed.
Telephone Based Cognitive Behavioral Therapy: Five biweekly sessions of telephone based, trauma focused cognitive behavioral therapy with homework assignment</description>
          </group>
          <group group_id="O2">
            <title>Waitlist Control Group</title>
            <description>Five weeks without active intervention, followed by assessment and referral to clinical treatment if needed.</description>
          </group>
        </group_list>
        <measure>
          <title>Severity of PTSD Symptoms</title>
          <description>Clinician Administered PTSD Scale for DSM IV (CAPS IV) Score range 0-136 points Score above 40 indicate probable PTSD PTSD diagnosis inferred using DSM IV diagnostic criteria</description>
          <population>Survivors of traumatic event with Acute PTSD symptoms one month after trauma exposure</population>
          <units>CAPS total Score at treatment end</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="73"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.4" lower_limit="33.9" upper_limit="45.8"/>
                    <measurement group_id="O2" value="43.9" lower_limit="41.3" upper_limit="51.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.927</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Cognitive Behavioral Therapy</title>
          <description>Five sessions of trauma-focused, telephone based cognitive behavioral therapy, followed by assessment and referral to clinical treatment if needed.
Telephone Based Cognitive Behavioral Therapy: Five biweekly sessions of telephone based, trauma focused cognitive behavioral therapy with homework assignment</description>
        </group>
        <group group_id="E2">
          <title>Waitlist Control Group</title>
          <description>Five weeks without active intervention, followed by assessment and referral to clinical treatment if needed.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="74"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="74"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Arieh Y. Shalev, M.D.</name_or_title>
      <organization>New York Langone Medical Center Department of Psychiatry</organization>
      <phone>6467544782</phone>
      <email>arieh.shalev@nyumc.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

